VWF and endothelial dysfunction: Increase in Von-willebrand factor antigen, endothelial dysfunction, alterations of clotting cascade, thromboxane-prostacyclin homeostatic disturbances, and stimulation of fibroblasts [1,7-9] add to the propensity of thrombotic events with cisplatin.